Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer

S. Komori, K. Takeda, S. Dobashi, N. Kadoya, Y. Fujita, K. Ito, Tokihiro Yamamoto, R. Umezawa, H. Matsushita, K. Jingu, K. Kishi, K. Sato

Research output: Contribution to journalArticle

Abstract

Our purpose was to determine clinical factors related to the regional body volume reduction rate (RBVRR) during radical external radiotherapy for head and neck cancer. 50 oropharyngeal and 62 hypopharyngeal cancer patients were enrolled and analyzed retrospectively. The median of RBVRR was 6.4% (range, 1.2-23.7%). A statistically significant RBVRR was observed in hypopharyngeal cancer patients with concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF regimen) (p = 0.04).

Original languageEnglish (US)
Pages (from-to)733-739
Number of pages7
JournalJapanese Journal of Clinical Radiology
Volume59
Issue number5
StatePublished - 2014
Externally publishedYes

Fingerprint

Hypopharyngeal Neoplasms
docetaxel
Head and Neck Neoplasms
Radiotherapy
Chemoradiotherapy
Fluorouracil
Cisplatin

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Komori, S., Takeda, K., Dobashi, S., Kadoya, N., Fujita, Y., Ito, K., ... Sato, K. (2014). Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer. Japanese Journal of Clinical Radiology, 59(5), 733-739.

Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer. / Komori, S.; Takeda, K.; Dobashi, S.; Kadoya, N.; Fujita, Y.; Ito, K.; Yamamoto, Tokihiro; Umezawa, R.; Matsushita, H.; Jingu, K.; Kishi, K.; Sato, K.

In: Japanese Journal of Clinical Radiology, Vol. 59, No. 5, 2014, p. 733-739.

Research output: Contribution to journalArticle

Komori, S, Takeda, K, Dobashi, S, Kadoya, N, Fujita, Y, Ito, K, Yamamoto, T, Umezawa, R, Matsushita, H, Jingu, K, Kishi, K & Sato, K 2014, 'Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer', Japanese Journal of Clinical Radiology, vol. 59, no. 5, pp. 733-739.
Komori, S. ; Takeda, K. ; Dobashi, S. ; Kadoya, N. ; Fujita, Y. ; Ito, K. ; Yamamoto, Tokihiro ; Umezawa, R. ; Matsushita, H. ; Jingu, K. ; Kishi, K. ; Sato, K. / Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer. In: Japanese Journal of Clinical Radiology. 2014 ; Vol. 59, No. 5. pp. 733-739.
@article{f99865158bb34c45ac2f0bc1a83d08fc,
title = "Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer",
abstract = "Our purpose was to determine clinical factors related to the regional body volume reduction rate (RBVRR) during radical external radiotherapy for head and neck cancer. 50 oropharyngeal and 62 hypopharyngeal cancer patients were enrolled and analyzed retrospectively. The median of RBVRR was 6.4{\%} (range, 1.2-23.7{\%}). A statistically significant RBVRR was observed in hypopharyngeal cancer patients with concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF regimen) (p = 0.04).",
author = "S. Komori and K. Takeda and S. Dobashi and N. Kadoya and Y. Fujita and K. Ito and Tokihiro Yamamoto and R. Umezawa and H. Matsushita and K. Jingu and K. Kishi and K. Sato",
year = "2014",
language = "English (US)",
volume = "59",
pages = "733--739",
journal = "Japanese Journal of Clinical Radiology",
issn = "0009-9252",
publisher = "Kanehara Shuppan Co. Ltd",
number = "5",

}

TY - JOUR

T1 - Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer

AU - Komori, S.

AU - Takeda, K.

AU - Dobashi, S.

AU - Kadoya, N.

AU - Fujita, Y.

AU - Ito, K.

AU - Yamamoto, Tokihiro

AU - Umezawa, R.

AU - Matsushita, H.

AU - Jingu, K.

AU - Kishi, K.

AU - Sato, K.

PY - 2014

Y1 - 2014

N2 - Our purpose was to determine clinical factors related to the regional body volume reduction rate (RBVRR) during radical external radiotherapy for head and neck cancer. 50 oropharyngeal and 62 hypopharyngeal cancer patients were enrolled and analyzed retrospectively. The median of RBVRR was 6.4% (range, 1.2-23.7%). A statistically significant RBVRR was observed in hypopharyngeal cancer patients with concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF regimen) (p = 0.04).

AB - Our purpose was to determine clinical factors related to the regional body volume reduction rate (RBVRR) during radical external radiotherapy for head and neck cancer. 50 oropharyngeal and 62 hypopharyngeal cancer patients were enrolled and analyzed retrospectively. The median of RBVRR was 6.4% (range, 1.2-23.7%). A statistically significant RBVRR was observed in hypopharyngeal cancer patients with concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF regimen) (p = 0.04).

UR - http://www.scopus.com/inward/record.url?scp=84902295658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902295658&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 733

EP - 739

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 5

ER -